Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Archives of Dermatological Research|September 1, 2021
Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwideM E van Muijen, L S van der Schoot, J M P A van den Reek, et al.Frontiers in Pharmacology|April 12, 2024
Dose reduction of biologics in patients with plaque psoriasis: a reviewC A M van Riel, C A J Michielsens, M E van Muijen, et al.Frontiers in Pharmacology|October 29, 2024
Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a reviewC A M van Riel, C A J Michielsens, M E van Muijen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2026
International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi studyC A M van Riel, W-H Boehncke, J L W Lambert, et al.Archives of Dermatological Research|February 22, 2023
Patients' perspectives towards biologic dose reduction in psoriasis: a qualitative studyL S van der Schoot, L M Verhoef, I van Ee, et al.The Journal of Dermatological Treatment|December 6, 2022
National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedureL S van der Schoot, E M Baerveldt, W A van Enst, et al.The Journal of Dermatological Treatment|March 3, 2023
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practiceL S van der Schoot, J J Janssen, M T Bastiaens, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2019
Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registryL S van der Schoot, J M P A van den Reek, J M M Groenewoud, et al.Pageof 1